Skip to content
‹ Back to IndustriesHealthcare

Decentralized At-Home Care: Following the Trends that Can Improve Healthcare in the U.S.

Decentralized at-home care is emerging as a significant trend with the potential to address healthcare equity and accessibility gaps in the United States. By shifting clinical services from hospitals to patients' homes, the model aims to reduce costs, improve patient outcomes, and reach underserved populations. The article explores the structural, technological, and policy factors driving this shift.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By David Kemp · · David KempDecentralized At-home CareDecentralized HealthcareExperts Talk
Share

Key takeaways

01

Moving care from hospitals to homes can reduce costs and improve access for underserved communities.

02

Technology enablers such as remote monitoring and telehealth are accelerating the decentralization of healthcare delivery.

03

Policy and reimbursement frameworks need to evolve to fully support sustainable at-home care models.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Decentralized At-Home Care in the U.S. is pivotal towards achieving equitable healthcare outcomes. Through the ability to leverage advancements like 5G to enhance service delivery and accessibility, this model, emphasizing at-home care, is emerging as a cornerstone for a more efficient and patient-centric approach, addressing the disparities inherent in traditional healthcare settings. As part of this decentralization, at-home care is not an alternative but a necessary evolution, offering tailored care within the comfort of patients’ homes, thereby redefining the healthcare landscape. It promises to make healthcare more accessible and equitable, particularly for underserved populations, by directly bringing diagnostics and treatment services to the patient.

At-home care is not an alternative but a necessary evolution, offering tailored care within the comfort of patients’ homes, thereby redefining the healthcare landscape.

With the pivot towards a decentralized at-home care model comes the potential to transform healthcare into a more inclusive, effective, and patient-focused system. How can these trends reshape the future of healthcare in the U.S., and what are the implications for patients, providers, and the healthcare system at large?

Experts Talk on MarketScale, hosted by David Kemp, brings together industry leaders to dissect the impact of decentralized at-home care on U.S. healthcare and explore strategies to support this trend. This episode features insights from Geoffrey Roche, the Director of Workforce Development at Siemens Healthineers, Josh Sol, the Managing Director of Healthcare Business Transformation at FTI Consulting, Dr. Jim Chen MD, MPH, the Chief Business Development Officer at IHDLab, and Larry Carlson, the Former President & CEO of United Methodist Communities, who bring diverse perspectives from their respective fields.

Main Points of Conversation:

  • The strategic and philosophical role of at-home, decentralized healthcare in the post-pandemic era
  • The impact of technology and regulatory changes on the adoption and success of at-home care
  • Challenges and opportunities in scaling at-home healthcare services to meet growing demand

Geoffrey Roche is an influential voice in healthcare discussions, particularly workforce development. His work at Siemens Healthineers has positioned him at the forefront of initiatives to equip healthcare professionals with the skills and knowledge necessary to thrive in a rapidly evolving industry landscape.

Josh Sol has carved out a niche in healthcare business transformation, leveraging his extensive experience to guide healthcare organizations through complex changes. His strategic insights have helped shape operational strategies that align with the shifting paradigms of healthcare delivery, emphasizing efficiency and patient-centered care.

Dr. Jim Chen stands out for his innovative contributions to healthcare technology and diagnostics. At IHDLab, he leads efforts to develop cutting-edge diagnostic tools that promise to revolutionize at-home care, making it more accessible and effective for patients across the spectrum of healthcare needs.

Larry Carlson brings a wealth of experience from his tenure as President & CEO of United Methodist Communities, where he focused on improving the quality of elder care. His dedication to enhancing dementia care and his visionary approach to senior living solutions have significantly impacted the field, contributing to the broader discourse on at-home healthcare.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

David Kemp
David KempHealthcare Lead

With experience in coaching college basketball, supporting large healthcare systems through ICD-10, to now leading the healthcare vertical at MarketScale, David enjoys the journey. Craving knowledge is one of David's core values, and he has the opportunity to learn from some of the best as host of the Highway to Health podcast series.

B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Hospitals can meet antibiotic stewardship rules without a full-time ID hire

Access TeleCare pharmacist Ashley Selby describes a telehealth antimicrobial stewardship model sized to each hospital's gaps. Joint Commission Standard MM.09.01.01 and 42 CFR 482.42 require a qualified physician and/or pharmacist leader, not a full-time hire, and a 14-study meta-analysis found telehealth stewardship cut antibiotic days of therapy without changing mortality.

  • 01Joint Commission Standard MM.09.01.01, in force since January 2023, requires a physician and/or pharmacist qualified in infectious diseases or stewardship to lead the program, and its committee note allows remote participation.
  • 02The Board of Pharmacy Specialties counts more than 2,380 BCIDP pharmacists nationally, while many small hospitals still assign stewardship to pharmacists without ID training.
  • 03A 14-study meta-analysis found telehealth stewardship raised guideline adherence and cut antibiotic days of therapy, but did not significantly change mortality.

Nov 9, 2026

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

David Kemp
David Kemp

Host, Experts Talk

David Kemp is a host and content producer at MarketScale, where he leads the Experts Talk series covering trends across a range of B2B industries. He focuses on synthesizing expert perspectives on emerging issues in healthcare, technology, and business. His work centers on making complex industry conversations accessible to broader audiences.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512